Trials / Completed
CompletedNCT03259269
Expand New Drugs for TB [endTB]
endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB With Regimens Containing Bedaquiline or Delamanid
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,804 (actual)
- Sponsor
- Partners in Health · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This observational study will examine the safety and efficacy of bedaquiline and delamanid used (individually, not together) in routine, multidrug regimens for treatment of MDR-TB. The information gathered in this study will inform doctors how best to use these TB drugs in the future.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | This is a non-intervention observational study | No applicable intervention; this is a secondary data analysis observational study. |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2019-09-30
- Completion
- 2019-12-30
- First posted
- 2017-08-23
- Last updated
- 2022-06-13
Locations
16 sites across 14 countries: Armenia, Bangladesh, Belarus, Burma, Ethiopia, Georgia, Indonesia, Kazakhstan, Kenya, Kyrgyzstan, Lesotho, Pakistan, Peru, South Africa
Source: ClinicalTrials.gov record NCT03259269. Inclusion in this directory is not an endorsement.